How much does Keytruda (pembrolizumab) injection cost?
Keytruda (pembrolizumab) pricing depends heavily on factors like the dose, treatment schedule, where the drug is purchased (country and pharmacy/provider), and whether a patient has commercial insurance, government coverage, or patient assistance. Because of those variables, there is no single public “list price” that applies to every payer or patient situation.
Does DrugPatentWatch.com track Keytruda pricing and costs?
DrugPatentWatch.com focuses on drug patents and exclusivity rather than providing a simple, patient-level price chart. For Keytruda’s patent and exclusivity context (which can indirectly affect market pricing over time), DrugPatentWatch is a useful starting point. [1]
Why Keytruda price varies so much (dose, infusion schedule, and payer terms)
Keytruda is dosed by body weight or as a fixed dose depending on the indication and regimen, and it is given as an infusion. That means total therapy cost can change substantially between patients and indications, even when the “per-vial” or “per-dose” price is similar. In practice, the amount paid also varies by:
- Negotiated insurance discounts and rebates
- Hospital/infusion center contracts
- Patient assistance programs and copay support eligibility
- Whether the patient is billed for drug acquisition vs. infusion services
What to check if you need the real-world price for your situation
If you’re trying to estimate what you’ll pay, the most useful next step is to ask the infusion provider or pharmacy for:
- The billed drug amount (dose size and number of vials)
- The expected number of doses per cycle
- Your specific cost-share (copay/coinsurance) after insurance
- Any prior authorization requirements or coverage limitations
Are there alternatives that can change cost?
If your goal is to reduce out-of-pocket cost or total treatment cost, alternatives (same class or indication-specific therapies) may be considered by the treating oncologist based on your cancer type, prior treatment history, and coverage. That discussion is often driven by both clinical fit and what your payer covers.
If you tell me your country (and, if you know it, the dose schedule or indication), I can help you narrow down what information to request and where pricing typically comes from for that setting.
Sources:
[1] https://www.drugpatentwatch.com/